Interaction between natural compounds and human topoisomerase I

被引:42
|
作者
Castelli, Silvia [1 ]
Coletta, Andrea [1 ]
D'Annessa, Ilda [1 ]
Fiorani, Paola [2 ]
Tesauro, Cinzia [1 ]
Desideri, Alessandro [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[2] CNR, Natl Res Council, Inst Translat Pharmacol, I-00133 Rome, Italy
关键词
enzymatic catalytic steps; inhibition mechanism; natural compounds; topoisomerase I; CONJUGATED EICOSAPENTAENOIC ACID; DNA TOPOISOMERASE; CAMPTOTHECIN RESISTANCE; LEISHMANIA-DONOVANI; LUOTONIN-A; ANTITUMOR PROPERTIES; CYTOTOXIC ACTIVITY; SINGLE MUTATION; BETA-LAPACHONE; CANCER-CELLS;
D O I
10.1515/hsz-2012-0240
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eukaryotic topoisomerase I (Top1) is a monomeric enzyme that catalyzes the relaxation of supercoiled DNA during important processes including DNA replication, transcription, recombination and chromosome condensation. Human Top1 I is of significant medical interest since it is the unique cellular target of camptothecin (CPT), a plant alkaloid that rapidly blocks both DNA and RNA synthesis. In this review, together with CPT, we point out the interaction between human Top1 and some natural compounds, such us terpenoids, flavonoids, stilbenes and fatty acids. The drugs can interact with the enzyme at different levels perturbing the binding, cleavage, rotation or religation processes. Here we focus on different assays that can be used to identify the catalytic step of the enzyme inhibited by different natural compounds.
引用
收藏
页码:1327 / 1340
页数:14
相关论文
共 50 条
  • [31] Interaction of clinically important human DNA topoisomerase I poison, topotecan, with double-stranded DNA
    Streltsov, S
    Oleinikov, V
    Ermishov, M
    Mochalov, K
    Sukhanova, A
    Nechipurenko, Y
    Grokhovsky, S
    Zhuze, A
    Pluot, M
    Nabiev, I
    BIOPOLYMERS, 2003, 72 (06) : 442 - 454
  • [32] Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I
    Olivier, A
    Lucie, K
    Jean-François, R
    Christian-Jacques, L
    Paule, S
    ONCOGENE, 2003, 22 (13) : 1945 - 1954
  • [33] A synergistic interaction between lapatinib and topoisomerase I inhibitors in cisplatin sensitive and resistant cancer cell lines
    Perry, J.
    Nsubuga, E.
    Joel, S.
    Shamash, J.
    El-Hariry, I.
    Powles, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Direct interaction between Escherichia coli RNA polymerase and the zinc ribbon domains of DNA topoisomerase I
    Cheng, BK
    Zhu, CX
    Ji, CL
    Ahumada, A
    Tse-Dinh, YC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) : 30705 - 30710
  • [35] Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I
    Ayrault Olivier
    Karayan Lucie
    Riou Jean-François
    Larsen Christian-Jacques
    Séité Paule
    Oncogene, 2003, 22 : 1945 - 1954
  • [36] The identification of a functional interaction between PKC and topoisomerase II
    Mouchel, NAP
    Jenkins, JR
    FEBS LETTERS, 2006, 580 (01) : 51 - 57
  • [37] Remote Sensing of the Interaction between Human and Natural Ecosystems in Asia
    Xue, Bing
    Xu, Yaotian
    Yang, Jun
    REMOTE SENSING, 2024, 16 (13)
  • [38] Interaction of flavonoid topoisomerase I and II inhibitors with DNA oligomers
    Bocian, W
    Kawecki, R
    Bednarek, E
    Sitkowski, J
    Ulkowska, A
    Kozerski, L
    NEW JOURNAL OF CHEMISTRY, 2006, 30 (03) : 467 - 472
  • [39] A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin
    Kerrigan, JE
    Pilch, DS
    BIOCHEMISTRY, 2001, 40 (33) : 9792 - 9798
  • [40] Comprehensive review on the interaction between natural compounds and brain receptors: Benefits and toxicity
    Silva, Ana R.
    Grosso, Clara
    Delerue-Matos, Cristina
    Rocha, Joao M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 174 : 87 - 115